Integra LifeSciences Holdings (IART)

Gross profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Gross profit	US$ in thousands	36,995	170,822	159,143	851,034	952,876
Revenue	US$ in thousands	1,486,360	1,506,670	1,533,950	1,298,690	1,461,480
Gross profit margin		2.49%	11.34%	10.37%	65.53%	65.20%

December 31, 2023 calculation

Gross profit margin = Gross profit ÷ Revenue
= $36,995K ÷ $1,486,360K
= 2.49%

Based on the data provided, Integra Lifesciences Holdings Corp's gross profit margins have exhibited some fluctuation over the past five years. The gross profit margin decreased from 62.79% in 2019 to 62.03% in 2020 but then improved to 61.24% in 2021. However, there was a further decline to 62.29% in 2022 and a more significant drop to 57.39% in 2023.

These variations in gross profit margins suggest changes in the company's cost of goods sold relative to its revenue. A declining gross profit margin may indicate an increase in production costs, pricing pressures, or other operational inefficiencies impacting the company's profitability.

Further analysis of the factors driving these fluctuations in gross profit margins, including cost management strategies, pricing decisions, and changes in sales volume, would be necessary to assess the overall health and efficiency of Integra Lifesciences Holdings Corp's operations.